Sunesis completes $39.06mm IPO
Sunesis Pharmaceuticals (therapeutics for cancer and inflammatory diseases) has netted $39.06mm with the initial public offering of 6mm common shares priced at $7 each. The company had originally hoped to bring in up to $86.25mm when it first filed in December 2004.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.